CALC
Price
$0.60
Change
-$0.01 (-1.64%)
Updated
Feb 4, 02:29 PM (EDT)
Capitalization
8.7M
Intraday BUY SELL Signals
REVB
Price
$1.66
Change
-$0.01 (-0.60%)
Updated
Feb 4, 03:11 PM (EDT)
Capitalization
4.38M
Intraday BUY SELL Signals
Interact to see
Advertisement

CALC vs REVB

Header iconCALC vs REVB Comparison
Open Charts CALC vs REVBBanner chart's image
CalciMedica
Price$0.60
Change-$0.01 (-1.64%)
Volume$1K
Capitalization8.7M
Revelation Biosciences
Price$1.66
Change-$0.01 (-0.60%)
Volume$3.1K
Capitalization4.38M
CALC vs REVB Comparison Chart in %
CALC
Daily Signal:
Gain/Loss:
REVB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CALC vs. REVB commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALC is a Buy and REVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (CALC: $0.61 vs. REVB: $1.67)
Brand notoriety: CALC and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CALC: 95% vs. REVB: 52%
Market capitalization -- CALC: $8.7M vs. REVB: $4.38M
CALC [@Biotechnology] is valued at $8.7M. REVB’s [@Biotechnology] market capitalization is $4.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALC’s FA Score shows that 1 FA rating(s) are green whileREVB’s FA Score has 2 green FA rating(s).

  • CALC’s FA Score: 1 green, 4 red.
  • REVB’s FA Score: 2 green, 3 red.
According to our system of comparison, both CALC and REVB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALC’s TA Score shows that 3 TA indicator(s) are bullish while REVB’s TA Score has 3 bullish TA indicator(s).

  • CALC’s TA Score: 3 bullish, 6 bearish.
  • REVB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, REVB is a better buy in the short-term than CALC.

Price Growth

CALC (@Biotechnology) experienced а -88.11% price change this week, while REVB (@Biotechnology) price change was -20.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CALC($8.7M) has a higher market cap than REVB($4.38M). CALC has higher P/E ratio than REVB: CALC (0.30) vs REVB (0.01). REVB YTD gains are higher at: -47.799 vs. CALC (-90.759). REVB has higher annual earnings (EBITDA): -8.22M vs. CALC (-32.41M). REVB has less debt than CALC: REVB (0) vs CALC (8.9M). CALC (0) and REVB (0) have equivalent revenues.
CALCREVBCALC / REVB
Capitalization8.7M4.38M199%
EBITDA-32.41M-8.22M394%
Gain YTD-90.759-47.799190%
P/E Ratio0.300.015,772%
Revenue00-
Total Cash14.1MN/A-
Total Debt8.9M0-
TECHNICAL ANALYSIS
Technical Analysis
CALCREVB
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CALC
Daily Signal:
Gain/Loss:
REVB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCVL19.730.31
+1.60%
Shoe Carnival
CURB24.450.15
+0.62%
Curbline Properties Corp
JLHL4.23-0.01
-0.24%
Julong Holding Limited
MKSI229.58-3.99
-1.71%
MKS Inc
WXM0.46-0.03
-6.84%
WF International Limited

CALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CALC has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CALC jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
-9.10%
REVB - CALC
48%
Loosely correlated
-11.17%
OBIO - CALC
33%
Poorly correlated
+1.49%
ABOS - CALC
28%
Poorly correlated
-0.77%
ALDX - CALC
26%
Poorly correlated
-0.37%
VTYX - CALC
26%
Poorly correlated
-0.07%
More

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with CALC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then CALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-11.17%
CALC - REVB
48%
Loosely correlated
-9.10%
GNPX - REVB
48%
Loosely correlated
-3.61%
OGEN - REVB
47%
Loosely correlated
-7.23%
TCRT - REVB
46%
Loosely correlated
-6.16%
ANL - REVB
36%
Loosely correlated
+1.40%
More